[go: up one dir, main page]

DK1129709T3 - Farmaceutisk sammensætning indeholdende ibuprofen og fremgangsmåde til fremstilling heraf - Google Patents

Farmaceutisk sammensætning indeholdende ibuprofen og fremgangsmåde til fremstilling heraf

Info

Publication number
DK1129709T3
DK1129709T3 DK01500053T DK01500053T DK1129709T3 DK 1129709 T3 DK1129709 T3 DK 1129709T3 DK 01500053 T DK01500053 T DK 01500053T DK 01500053 T DK01500053 T DK 01500053T DK 1129709 T3 DK1129709 T3 DK 1129709T3
Authority
DK
Denmark
Prior art keywords
preparation
pharmaceutical composition
ibuprofen
composition containing
mixing
Prior art date
Application number
DK01500053T
Other languages
English (en)
Inventor
Perez Maria Teresa Tarre
Faus Xavier Font
Casas Montserrat Trullols
Original Assignee
Aplicaciones Farmacodinamicas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aplicaciones Farmacodinamicas filed Critical Aplicaciones Farmacodinamicas
Application granted granted Critical
Publication of DK1129709T3 publication Critical patent/DK1129709T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK01500053T 2000-03-03 2001-03-01 Farmaceutisk sammensætning indeholdende ibuprofen og fremgangsmåde til fremstilling heraf DK1129709T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200000522A ES2171110B1 (es) 2000-03-03 2000-03-03 Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion.

Publications (1)

Publication Number Publication Date
DK1129709T3 true DK1129709T3 (da) 2005-10-24

Family

ID=8492565

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01500053T DK1129709T3 (da) 2000-03-03 2001-03-01 Farmaceutisk sammensætning indeholdende ibuprofen og fremgangsmåde til fremstilling heraf

Country Status (8)

Country Link
EP (1) EP1129709B1 (da)
AT (1) ATE298567T1 (da)
CZ (1) CZ301553B6 (da)
DE (1) DE60111657T2 (da)
DK (1) DK1129709T3 (da)
ES (1) ES2171110B1 (da)
PT (1) PT1129709E (da)
SK (1) SK285338B6 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
WO2007055887A1 (en) * 2005-11-02 2007-05-18 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
EP1840188B1 (en) 2006-03-31 2011-09-07 Sony Deutschland GmbH A composition comprising at least one type of liquid crystal
ES2303468B1 (es) * 2007-01-22 2009-06-08 Masterfarm, S.L "una composicion farmaceutica pulverulenta que comprende ibuprofeno".
EP1974751A1 (en) * 2007-03-26 2008-10-01 The Jordanian Pharmaceutical Manufacturing Co. Formulations for non-steroidal anti-inflammatory drugs
FR2914187B1 (fr) * 2007-03-28 2011-01-21 Pf Medicament Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique.
HUE029953T2 (en) 2009-04-27 2017-04-28 Laboratorio De Aplicaciones Farm S A Oral ibuprofen lysate suspension
TW201038296A (en) * 2009-04-27 2010-11-01 Aplicaciones Farmacodinamicas S A Lab De Ibuprofen lysinate oral suspension
WO2014194872A1 (en) 2013-06-04 2014-12-11 Zentiva, K.S. Taste masking of water soluble drugs using poloxamers
WO2024246565A2 (en) 2023-06-02 2024-12-05 Ioulia Tseti Pharmaceutical composition comprising ibuprofen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
DE4038314A1 (de) * 1990-11-30 1992-06-04 Puetter Medice Chem Pharm Komplexe des aktiven enantiomers des ibuprofens mit cyclodextrin
GB9207990D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Pharmaceutical composition
GB9316580D0 (en) * 1993-08-10 1993-09-29 Smithkline Beecham Plc Pharmaceutical composition
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
ATE298567T1 (de) 2005-07-15
ES2171110A1 (es) 2002-08-16
SK2932001A3 (en) 2001-12-03
EP1129709A3 (en) 2001-11-14
DE60111657T2 (de) 2006-05-04
EP1129709B1 (en) 2005-06-29
EP1129709A2 (en) 2001-09-05
ES2171110B1 (es) 2003-06-16
PT1129709E (pt) 2005-10-31
DE60111657D1 (de) 2005-08-04
CZ2001714A3 (cs) 2001-10-17
CZ301553B6 (cs) 2010-04-14
SK285338B6 (sk) 2006-11-03

Similar Documents

Publication Publication Date Title
DE69811233D1 (de) Feste lösungen und dispersionen von eines schlecht wasserlöslichen wirkstoffes
DK1381432T3 (da) HSA-frie interferon-beta-præparater
IL165601A0 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
HK1096034A1 (en) A solid dosage form comprising a fibrate
DK0548114T5 (da) Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette
DK1129709T3 (da) Farmaceutisk sammensætning indeholdende ibuprofen og fremgangsmåde til fremstilling heraf
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
DE602004019777D1 (de) STABILE PHARMAZEUTISCHE ZUBEREITUNGEN MIT 2-AZA-BICYCLOi3.3.0 -OCTAN-3-CARBOXYLSÄURE-DERIVATEN
RS53804A (en) Parenteral composition of paracetamol
WO2003020214A3 (en) Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
WO2003028624A3 (en) Levothyroxine compositions and methods
IL163608A (en) Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders
HUT60245A (en) Insecticidal compositions comprising 2-aryl-1-(alkoxymethyl)-4-halogen-5-(trifluoromethyl)-pyrrole derivatives as active ingredient and process for producing the active ingredient
NO20010537D0 (no) Farmasöytiske preparater omfattende ibuprofen og domperidon
HRP20000781B1 (en) Effervescent preparations
JPS5781409A (en) External plaster
WO2003013441A3 (en) Levothyroxine compositions and methods
BE2016C017I2 (da)
NO20054417L (no) Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter
WO2004014318A3 (en) Levothyroxine compositions and methods
SE8402199D0 (sv) Pharmazeutisches preparat enthaltend co-dergocrine und einen calcium-antagonisten
GEP20053581B (en) Pharmaceutical Composition and Method for Preparation Thereof
SE9902742D0 (sv) New pharmaceutical formultion
IT9022371A0 (it) Derivati dell'1-arilsolfonil 2-pirrolidone, loro procedimento di preparazione e i nuovi intermedi cosi' ottenuti, il loro impiego come farmaci e le composizioni farmaceutiche che li contengono.
MXPA03007332A (es) Composiciones de levotiroxina y metodos para elaborar la misma.